Commercial Products and Services
Compliance and Voluntary Disclosure
Foreign Sales/International Government Contracts
Government Finance & Privatization
Military Bases and Communities
Defensive Measures and Emergency Preparedness
Public Policy and Legislative Action
Public Health and Pharmaceutical Compliance
Radio Frequency Identification (RFID)
State and Local Government Contracts
Teaming Agreements and Subcontracts
Intellectual Property and Technology
McKenna Long & Aldridge has one of the broadest, most experienced practices in the area of public health procurement, federal health care programs, biodefense and the marketing and sales practices of pharmaceuticals, biotechs and medical suppliers. Our practice focuses on laws and regulations affecting the types of relationships with the federal government.
Medicare Contracting and Government Procurement
McKenna Long & Aldridge attorneys have extensive experience in handling all aspects of the special contracts issues arising under contracts with the Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS). We have a long history of counseling clients who perform as Carriers and Intermediaries in support of CMS' federal Medicare Part A and Part B, Durable Medical Equipment, Program Safeguard and other federally-funded healthcare programs and contract requirements, clients who compete for and perform contracts to provide similar services in connection with the Tricare and Federal Employee Health Benefit (FEHB) health care programs, and clients who contract with state Medicaid agencies.
We are currently counseling a number of companies concerned with the statutorily required transition from CMS' traditional "Title XVIII" contracting practices to practices compliant with the Cost Accounting Standards (CAS) and the Federal Acquisition Regulation (FAR). We are also counseling companies concerning CMS' consolidation of its traditional contracts into bundled services contracts known as Medicare Administrative Contracts.
We routinely assist companies which are establishing a relationship and familiarizing themselves with CMS. In the current dynamic contracting environment, we help companies enter into Medicare and other federally-funded healthcare program contracts. In addition, we help our "incumbent" CMS contractor clients to adjust to the CMS' transition to FAR/CAS-based government contracts. Further, we support companies in their efforts to recover termination costs after the severance of their contract relationship(s) with the CMS.
Our experience includes:
Pharmaceutical and Medical Supplier Public Sector Business
The Public Health and Pharmaceutical Compliance practice group provides a wide variety of services to clients that supply pharmaceuticals and medical devices to the federal government and its beneficiaries under federally funded health care programs. The group:
Our practice involves agencies such as Health and Human Services (HHS), Defense (DOD) and Veteran's Affairs (VA) in procurement related litigation and False Claims Act prosecutions in the Federal District Courts. Beginning in 1993 -- after passage of the Veteran's Health Care Act -- we began conducting compliance audits for pharmaceutical companies relating to their VA, DOD and PHS pricing and now have consulted with over forty pharmaceuticals on their compliance initiatives relating to public sector business.
We are counsel to the Coalition for Federal Procurement, which has as members twenty-five pharmaceutical companies with interests in VA and DOD pharmaceutical pricing. Our lead lawyers attend the Coalition's monthly meetings to assist it in forming an appropriate agenda of issues for the Coalition to take up with the Under Secretary's of Health at DOD and VA and advising the Coalition on legal issues of common interest to the member pharmaceutical companies.
Our lawyers are active members of the American Bar Association's Healthcare Contracting Committee where we coordinate an annual CLE program on public sector pharmaceutical pricing and serve in leadership capacities.
For more news on biodefense and Project BioShield, please click here.